Under the agreement, GSK will pay $1billion upfront to acquire the Massachussetts-based firm, followed by up to $150million in ‘success-based’ milestone payments.Read More

You might also be interested in reading Charted: Chainlink (LINK) Remains In Strong Uptrend, Why It Could Test $25.